MMP9 and breast cancer: It should be taken into consideration that several studies have reported that HO-1 activation prevents breast cancer proliferation [140] and prostate cancer angiogenesis [141] and mediates the anticancer activity of some drugs such as andrographolide by reducing the MMP-9 expression in breast cancer cells [142].